Coverage
-
September 14, 2015
A Pennsylvania federal judge on Friday suspended a false advertising suit by GlaxoSmithKline LLC against Teva Pharmaceuticals USA Inc. over Teva's marketing of its generic Wellbutrin as equivalent to the brand-name drug, though another similar suit is going forward.
1 other articles on this case.
View all »